Tumor Stem Cell Assay

"Tumor Stem Cell Assay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A cytologic technique for measuring the functional capacity of tumor stem cells by assaying their activity. It is used primarily for the in vitro testing of antineoplastic agents.

Descriptor ID	D014410
MeSH Number(s)	E01.370.225.500.383.910 E01.370.225.500.388.930 E05.200.500.383.910 E05.200.500.388.930 E05.242.383.910 E05.242.417.500 E05.337.550.200.800
Concept/Terms	Tumor Stem Cell Assay Tumor Stem Cell Assay Colony Forming Units Assay, Tumor Neoplasm Stem Cell Assay Stem Cell Assay, Tumor Clonogenic Cell Assay, Tumor Colony-Forming Units Assay, Tumor

Below are MeSH descriptors whose meaning is more general than "Tumor Stem Cell Assay".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Cytological Techniques [E01.370.225.500]
Colony-Forming Units Assay [E01.370.225.500.383]
Tumor Stem Cell Assay [E01.370.225.500.383.910]
Drug Screening Assays, Antitumor [E01.370.225.500.388]
Tumor Stem Cell Assay [E01.370.225.500.388.930]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Cytological Techniques [E05.200.500]
Colony-Forming Units Assay [E05.200.500.383]
Tumor Stem Cell Assay [E05.200.500.383.910]
Drug Screening Assays, Antitumor [E05.200.500.388]
Tumor Stem Cell Assay [E05.200.500.388.930]
Cytological Techniques [E05.242]
Colony-Forming Units Assay [E05.242.383]
Tumor Stem Cell Assay [E05.242.383.910]
Drug Screening Assays, Antitumor [E05.242.417]
Tumor Stem Cell Assay [E05.242.417.500]
Evaluation Studies as Topic [E05.337]
Drug Evaluation, Preclinical [E05.337.550]
Drug Screening Assays, Antitumor [E05.337.550.200]
Tumor Stem Cell Assay [E05.337.550.200.800]

Below are MeSH descriptors whose meaning is related to "Tumor Stem Cell Assay".

Below are MeSH descriptors whose meaning is more specific than "Tumor Stem Cell Assay".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Tumor Stem Cell Assay" by people in this website by year, and whether "Tumor Stem Cell Assay" was a major or minor topic of these publications.

Bar chart showing 20 publications over 11 distinct years, with a maximum of 5 publications in 2014

To see the data from this visualization as text, click here.

Year	Minor Topic	Total
1998	1	1
2004	1	1
2007	1	1
2008	2	2
2010	1	1
2011	2	2
2012	2	2
2013	2	2
2014	5	5
2018	1	1
2021	2	2

Below are the most recent publications written about "Tumor Stem Cell Assay" by people in Profiles.

Fu Y, Katsaros D, Biglia N, Wang Z, Pagano I, Tius M, Tiirikainen M, Rosser C, Yang H, Yu H. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/?-catenin pathway and associates with favorable prognosis of ovarian cancer. Sci Rep. 2021 04 05; 11(1):7484.

View in: PubMed
Ge X, Niture S, Lin M, Cagle P, Li PA, Kumar D. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8. Sci Rep. 2021 03 11; 11(1):5660.

View in: PubMed
Chamcheu JC, Rady I, Chamcheu RN, Siddique AB, Bloch MB, Banang Mbeumi S, Babatunde AS, Uddin MB, Noubissi FK, Jurutka PW, Liu YY, Spiegelman VS, Whitfield GK, El Sayed KA. Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling. Int J Mol Sci. 2018 Jun 16; 19(6).

View in: PubMed
Dhanjal JK, Nigam N, Sharma S, Chaudhary A, Kaul SC, Grover A, Wadhwa R. Embelin inhibits TNF-a converting enzyme and cancer cell metastasis: molecular dynamics and experimental evidence. BMC Cancer. 2014 Oct 22; 14:775.

View in: PubMed
Peng B, Lei N, Chai Y, Chan EK, Zhang JY. CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer. Mol Biosyst. 2015 Jan; 11(1):105-14.

View in: PubMed
Maher DM, Khan S, Nordquist JL, Ebeling MC, Bauer NA, Kopel L, Singh MM, Halaweish F, Bell MC, Jaggi M, Chauhan SC. Ormeloxifene efficiently inhibits ovarian cancer growth. Cancer Lett. 2015 Jan 28; 356(2 Pt B):606-12.

View in: PubMed
Liu X, Peng B, Li Y, Lei N, Li W, Zhang JY. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Mol Biol Rep. 2014 Nov; 41(11):7471-8.

View in: PubMed
Zeng W, Chen X, Ma Y, Huang Z, Qin Y, Wu F, Wu L, Liang X, Qin Y, Zhou J, Lu D, Kuang X, Li QQ, Luo Z. A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line. Anticancer Res. 2014 Jan; 34(1):117-23.

View in: PubMed
Gupta BK, Maher DM, Ebeling MC, Stephenson PD, Puumala SE, Koch MR, Aburatani H, Jaggi M, Chauhan SC. Functions and regulation of MUC13 mucin in colon cancer cells. J Gastroenterol. 2014 Oct; 49(10):1378-91.

View in: PubMed
Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, Puumala SE, Jaggi M, Chauhan SC. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013 Aug; 12(8):1471-80.

View in: PubMed

People

Explore

Similar Concepts

Top Journals